Lungs News and Research

RSS

Stroke survivors have twice the risk of dementia compared to stroke-free men and women of the same age

The risk of dementia increases dramatically with advancing age. Our results show that sustaining a stroke increases this risk even further,” said lead author Cristina S. Ivan, M.D. a fellow in stroke and cerebrovascular disorders at the Boston Medical Center. “Dementia is a growing problem because of the aging of the population, particularly the ‘baby boomers’.

29 Apr 2004

Time bomb in heart leads to heart failure in some congenital heart disease patients

However, surgical correction of certain forms of congenital heart disease may not fix the underlying molecular trigger that drives progressive heart failure and sudden death later in life, according to new research from the University of California, San Diego (UCSD) School of Medicine.

29 Apr 2004

Researchers find mucus plays key role in cancer

Investigators at the Dana-Farber/Harvard Cancer Center in Boston became intrigued with the thick, slimy stuff when they learned that breast, lung, colon, and other tumor cells make more than 50 times more of a certain type of it than normal cells.

29 Apr 2004

Mutation of a gene involved in non-small cell lung cancer linked to drug effectiveness

Mutation of a gene involved in non-small cell lung cancer (NSCLC) increases the likelihood that the drug gefitinib (Iressa™) will show a beneficial response, researchers at the Dana-Farber Cancer Institute, the National Cancer Institute (NCI) - part of the National Institutes of Health - and two other institutions announced today in the online version of Science.

29 Apr 2004

Millions of poor and minority children in America's cities likely will suffer higher rates of asthma

Millions of poor and minority children in America's cities likely will suffer even higher rates of asthma as the result of a "powerful one-two punch" of higher levels of pollen and changes in the types of molds spurred by global warming, along with unhealthy urban air masses caused by the burning of fossil fuel by cars, trucks and buses, according to a warning issued today by Harvard researchers and the American Public Health Association (APHA).

29 Apr 2004

High levels of microscopic, soot-like particles are increasing the risk of premature death

High levels of microscopic, soot-like particles are increasing the risk of premature death for millions of people, including those with heart or lung disease, according to the American Lung Association State of the Air: 2004 report released today.

29 Apr 2004

Mothers who smoke increase the likelihood of daughters smoking 3 fold

The illusion of smoking can be just as deadly as the real thing for minority inner-city girls who believe their mothers have the habit, a new University of Florida study finds.

28 Apr 2004

Exercise provides therapeutic benefits, such as easing fatigue during radiation treatments

Doctors have known for quite awhile that exercise plays a role in preventing some cancers. But in a new twist, a researcher at the James C. Wilmot Cancer Center is studying whether exercise provides therapeutic benefits, such as easing fatigue during radiation treatments.

28 Apr 2004

The world's smallest computer made entirely of biological molecules

The world's smallest computer (around a trillion can fit in a drop of water) might one day go on record again as the tiniest medical kit.

28 Apr 2004

$4.5 million contract to develop heart assist devices for infants

The University of Pittsburgh's McGowan Institute for Regenerative Medicine has been awarded a five-year $4.5 million contract from the National Heart, Lung, and Blood Institute to develop a heart assist device for infants.

28 Apr 2004

Philippines tightens SARS screening at all entry points

The Philippine Department of Health (DOH) is assuring the public that there is no immediate threat of Severe Acute Respiratory Syndrome (SARS) in the country despite the new cases found in neighboring China.

28 Apr 2004

$11 million for lung injury research

Northwestern University has received an $11 million Program Project Grant (PPG) from the National Institutes of Health to define the mechanisms that cause changes in the alveolar epithelium during lung injury.

27 Apr 2004

BioTime awarded a research grant for blood plasma volume expander

BioTime, Inc. has announced that it has been awarded a research grant by the National Heart, Lung, and Blood Institute division of the National Institutes of Health (NIH) for use in the development of its HetaCool® blood plasma volume expander following peer review.

27 Apr 2004

FDA mandates approval for all pancreatic enzyme replacements

The Cystic Fibrosis Foundation has announced its support of the Food and Drug Administration's (FDA) requirement that manufacturers of pancreatic enzyme replacements obtain FDA approval for their products within the next four years.

27 Apr 2004

California has set a public health goal for arsenic levels in drinking water

The California Environmental Protection Agency’s Office of Environmental Health Hazard Assessment (OEHHA) today announced the publication of a final Public Health Goal (PHG) for arsenic in drinking water.

27 Apr 2004

Inspire announces positive results in cystic fibrosis study

Inspire Pharmaceuticals, Inc. today announced top-line results in a Phase II study of INS37217 Respiratory in patients with mild cystic fibrosis (CF) lung disease.

27 Apr 2004

Britain wheezes at bottom of European lung league

Data from The European Respiratory Society’s (ERS) new European Lung White Book shows that the death rate from respiratory diseases in the UK is 105 per 100,000 people, which is twice the EU average. The only countries with a higher rate are former Soviet Union countries - Kyrgyzstan, Kazakhstan, Turkmenistan and Uzbekistan – and Ireland.

27 Apr 2004

How clean are your lungs?

The airways that conduct air into and out of the lung contain secretions - mucus - that trap inhaled particles. These are removed from the lung by a process called mucociliary clearance that moves the mucus, dead cells and inhaled particles and microorganisms towards the throat from where they are swallowed.

27 Apr 2004

Clinical trial of enzyme replacement therapy for the treatment of Gaucher disease

Transkaryotic Therapies, Inc. today announced that it has initiated a clinical trial to evaluate the safety and clinical activity of GA-GCB, its enzyme replacement therapy for the treatment of Gaucher disease.

26 Apr 2004

New cancer drug Tarceva - a breakthrough with significant survival benefit in patients with advanced lung cancer

OSI Pharmaceuticals, Inc., Genentech, Inc., and Roche today announced that a Phase III study of Tarceva™ (erlotinib HCl), an investigational HER1/EGFR-inhibitor agent in previously treated patients with non-small cell lung cancer (NSCLC), met its primary endpoint of improving overall survival, with patients receiving Tarceva™ living longer than those in the placebo arm of the study.

26 Apr 2004

Lungs News and Research

Stroke survivors have twice the risk of dementia compared to stroke-free men and women of the same age

Time bomb in heart leads to heart failure in some congenital heart disease patients

Researchers find mucus plays key role in cancer

Mutation of a gene involved in non-small cell lung cancer linked to drug effectiveness

Millions of poor and minority children in America's cities likely will suffer higher rates of asthma

High levels of microscopic, soot-like particles are increasing the risk of premature death

Mothers who smoke increase the likelihood of daughters smoking 3 fold

Exercise provides therapeutic benefits, such as easing fatigue during radiation treatments

The world's smallest computer made entirely of biological molecules

$4.5 million contract to develop heart assist devices for infants

Philippines tightens SARS screening at all entry points

$11 million for lung injury research

BioTime awarded a research grant for blood plasma volume expander

FDA mandates approval for all pancreatic enzyme replacements

California has set a public health goal for arsenic levels in drinking water

Inspire announces positive results in cystic fibrosis study

Britain wheezes at bottom of European lung league

How clean are your lungs?

Clinical trial of enzyme replacement therapy for the treatment of Gaucher disease

New cancer drug Tarceva - a breakthrough with significant survival benefit in patients with advanced lung cancer

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News